These observations are interestingly in agreement with the previously mentioned differential signatures between CAC and CRC, and support the hypothesis that RAC1/RHOA pathway might be subjected to a different regulation in colorectal cancer in IBD patients [93]. This evidence concerns the gene RAC1 and colorectal carcinoma.